Thus, the objective of the present study was to analyze the mechanisms by which the IgG fraction found in SSc patients modulates signalling through PAR-1 and affects IL-6 secretion by human endothelial cells (ECs) (Figure 1). This evidence concerns the gene IL6 and systemic sclerosis.